Back
Gyre Therapeutics, Inc. Stock Predictions
Washington Wants Your Money. Here's How to Opt Out.
Learn how to become your own bank. Watch the free training.
Sell
47
GYRE
Gyre Therapeutics, Inc.
Last Price:
$6.81
Seasonality Move:
12.42%
7 Day Trial
ALL ACCESS PASS
$
7
Where Smart Money Buys Crypto (Hint: Not Coinbase)
Access Native Markets before the next 100x asset goes mainstream. Watch free training.Gyre Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Gyre Therapeutics, Inc. has on average historically risen by 38.8% based on the past 19 years of stock performance.
-
Gyre Therapeutics, Inc. has risen higher in 6 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 31.58%
-
Is Gyre Therapeutics, Inc. Stock Undervalued?The current Gyre Therapeutics, Inc. [GYRE] share price is $7.06. The Score for GYRE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
GYRE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Gyre Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Gyre Therapeutics, Inc. has on average historically risen by 38.8% based on the past 19 years of stock performance.
Gyre Therapeutics, Inc. Stock Rating
Sell
47
Gyre Therapeutics, Inc. (GYRE)
is a Sell
Is Gyre Therapeutics, Inc. overpriced?
-
Gyre Therapeutics, Inc. has risen higher in 6 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 31.58%
Gyre Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
gyretx.com
52-Week Data
52-Week High:
13.75
52-Week Low:
6.11
Prediction Charts
Market Cap:
680.1M
Price in USD:
7.06
Volume:
61.9K
Beta:
2.58
Technical Analysis
SMA50:
7.68
SMA100:
7.72
SMA200:
8.07
52-Wk Change:
-41.65%
Stock Predictions
-
Is Gyre Therapeutics, Inc. stock public?Yes, Gyre Therapeutics, Inc. is a publicly traded company.
-
What is the Gyre Therapeutics, Inc. stock quote today?The Gyre Therapeutics, Inc. stock price is 7.06 USD today.
-
How to buy Gyre Therapeutics, Inc. stock online?You can buy Gyre Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-11 | 8.38 | 7.87 | 8.38 | 7.80 |
| Dec-12 | 7.90 | 7.69 | 8.09 | 7.67 |
| Dec-15 | 7.77 | 7.54 | 7.88 | 7.48 |
| Dec-16 | 7.59 | 7.58 | 7.61 | 7.36 |
| Dec-17 | 7.55 | 7.41 | 7.70 | 7.34 |
| Dec-18 | 7.55 | 7.35 | 7.56 | 7.18 |
| Dec-19 | 7.30 | 7.13 | 7.35 | 6.92 |
| Dec-22 | 7.19 | 7.19 | 7.39 | 7.11 |
| Dec-23 | 7.25 | 7.18 | 7.38 | 7.16 |
| Dec-24 | 7.23 | 7.19 | 7.23 | 7.05 |
| Dec-26 | 7.30 | 7.26 | 7.35 | 7.18 |
| Dec-29 | 7.18 | 7.16 | 7.27 | 7.12 |
| Dec-30 | 7.17 | 7.02 | 7.17 | 6.98 |
| Dec-31 | 7.02 | 7.06 | 7.06 | 6.90 |
Gyre Therapeutics, Inc. Earnings
Gyre Therapeutics, Inc. Earnings Report: Per Share Gyre Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Gyre Therapeutics, Inc. Forecast Revenue Growth
Gyre Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Gyre Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.22 per share.
* Gyre Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.